Safety study of Wegovy exposure during pregnancy
Part of Hormones & metabolism clinical trials.
This study tracks the safety of taking Wegovy during pregnancy. Researchers want to understand potential risks and outcomes when people are exposed to Wegovy in early or any stage of pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent before any study steps begin
- You are female and between 15 and 50 years old when you sign
- You are currently pregnant or were recently pregnant
- You live in a country where the study is enrolling
- Your doctor can share your information with a pregnancy safety registry
- You were exposed to Wegovy at least once during pregnancy for weight control (if you were not exposed, you must still have obesity or overweight with at least one related health condition)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at health outcomes for pregnant women and their babies after taking Wegovy or other weight-loss medicines. It may help understand if these medicines are safe during pregnancy.
This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.
This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.
This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.
This trial tests an experimental drug called WVE-007 for people who are overweight or have obesity. It aims to help with weight loss and is looking at both a group without diabetes and a group with prediabetes or type 2 diabetes.
This study is looking at weight changes and factors that affect weight loss in people with severe or complicated obesity who have already started taking Wegovy. Researchers hope to learn what helps predict success with this medication.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.